Generic Parnate, which is manufactured by Par Pharmaceuticals and sold as Tranylcypromine tablets, is available in a 10 mg strength. The FDA has given generic Parnate an "AB" rating, meaning it is equivalent to the brand-name version (although the inactive ingredients may be different).
Parnate® (tranylcypromine sulfate) is a prescription medication that has been licensed as a depression treatment. It is part of a class of medicines known as monoamine oxidase inhibitors (MAOIs).
Brand-name Parnate is manufactured by GlaxoSmithKline. However, it has come off patent and is available as a generic.
Generic Parnate tablets are available in one strength -- Tranylcypromine 10 mg tablets.
Currently, generic Parnate is made by one company -- Par Pharmaceuticals.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. Generic tranylcypromine has an "AB" rating, meaning it should be equivalent to Parnate.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers or dyes or other ingredients that may cause problems for people with allergies or sensitivities.